Company: DMAAR
Filing Date: 2025-05-20
Form Type: 10-Q
Source: 0001213900-25-046061
Chunk: 83

Company: Drugs Made In America Acquisition Corp.
Filing Date: 2025-05-20
Form: 10-Q
Item: Part I, Item 8
Chunk 83
---
     
    Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
  
    32.2*
     
    Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
  
    101.CAL
     
    XBRL Taxonomy Extension Calculation Linkbase Document
  
    101.SCH
     
    XBRL Taxonomy Extension Schema Document
  
    101.DEF
     
    XBRL Taxonomy Extension Definition Linkbase Document
  
    101.LAB
     
    XBRL Taxonomy Extension Labels Linkbase Document
  
    101.PRE
     
    XBRL Taxonomy Extension Presentation Linkbase Document
  
    104
     
    Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

*Furnished herewith

25

SIGNATURES

Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto
duly authorized.

    Date: May 20, 2025
    DRUGS MADE IN AMERICA ACQUISITION CORP.

    By:
    /s/ Lynn Stockwell

    Name:  
    Lynn Stockwell

    Title: 
    Chief Executive Officer 

    (Principal Executive Officer)

    By:
    /s/ Glenn Worman

    Name: 
    Glenn Worman

    Title: 
    Chief Financial Officer 

    (Principal Financial and Accounting Officer)

26

0002028614
false
Q1
--12-31

    0002028614

    2025-01-01
    2025-03-31

    0002028614
    
      dmaau:UnitsMember

    2025-01-01
    2025-03-31

    0002028614
    
      us-gaap:CommonStockMember

    2025-01-01
    2025-03-31

    0002028614
    
      dmaau:RightMember

    2025-01-01
    2025-03-31

    000202